Literature DB >> 6334716

Selective inhibition of growth factor-dependent human B cell proliferation by monoclonal antibody AB1 to an antigen expressed by activated B cells.

L K Jung, S M Fu.   

Abstract

A monoclonal antibody, AB1, was established with activated human B cells as immunogen. AB1 stained activated B cells but not activated T cells. Its selective reactivity to activated B cells was further documented by its nonreactivity to activated T cells, resting T and B cells, monocytes, granulocytes, bone marrow cells, leukemic cells, and cells from cell lines of T, B, and myeloid lineages. Upon activation, the antigen appeared on B cells as early as 3-4 h after stimulation and was fully expressed by 38 h. The expression of this antigen was not dependent on the presence of B cell stimulatory factor(s). Anti-IgM antibodies by themselves induced its expression. AB1 inhibited B cell proliferation that was induced by a low dose anti-IgM antibody and conditioned medium containing B cell stimulatory factor. It did not inhibit B cell proliferation induced by either high doses of anti-IgM antibodies or by formalinized Staphylococcus aureus. It also failed to inhibit T cell mitogenesis. The possibility exists that this antigen is related to the receptor for B cell stimulatory factor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334716      PMCID: PMC2187532          DOI: 10.1084/jem.160.6.1919

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.

Authors:  D A Thorley-Lawson; R T Schooley; A K Bhan; L M Nadler
Journal:  Cell       Date:  1982-09       Impact factor: 41.582

2.  Nomenclature for lymphokines regulating B lymphocytes.

Authors:  W E Paul
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

3.  Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes.

Authors:  N Chiorazzi; S M Fu; H G Kunkel
Journal:  Clin Immunol Immunopathol       Date:  1980-03

4.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

5.  Biochemical separation of a human B cell mitogenic factor.

Authors:  A Maizel; C Sahasrabuddhe; S Mehta; J Morgan; L Lachman; R Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

Review 6.  Regulation of B-cell growth and differentiation by soluble factors.

Authors:  M Howard; W E Paul
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

7.  Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.

Authors:  S F Slovin; D M Frisman; C D Tsoukas; I Royston; S M Baird; S B Wormsley; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class.

Authors:  S H Yen; F Gaskin; S M Fu
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

9.  Polyclonal activation of human lymphocytes in vitro. I. Characterization of the lymphocyte response to a T cell-independent B cell mitogen.

Authors:  R K Schuurman; E W Gelfand; H M Dosch
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

10.  B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.

Authors:  T Yokochi; R D Holly; E A Clark
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

View more
  10 in total

Review 1.  Functional B-lymphocyte surface antigens.

Authors:  J T Golay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

2.  NDA3: a differentiation antigen associated with the receptor for B cell growth factor.

Authors:  N Suciu-Foca; C Rohowsky-Kochan; S J Rosochacki; E Cristea; J D Cai; E Reed; D W King
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 3.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

4.  An activation antigen on a subpopulation of B lymphocytes identified by the monoclonal antibody CMRF-17.

Authors:  S F Peach; S E Davidson; J L McKenzie; J C Nimmo; D N Hart
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

5.  Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency.

Authors:  L K Jung; S M Fu; T Hara; N Kapoor; R A Good
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

6.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

Authors:  E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 7.  Surface antigens associated with human B cell activation.

Authors:  L K Jung
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

8.  Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.

Authors:  B D Hock; G C Starling; P B Daniel; D N Hart
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

9.  Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor.

Authors:  J L Ambrus; C H Jurgensen; E J Brown; A S Fauci
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

10.  Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens.

Authors:  T Hara; L K Jung; J M Bjorndahl; S M Fu
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.